Associated Papers
Genetic association of beta-lactams-induced hypersensitivity reactions: A systematic review of genome-wide evidence and meta-analysis of candidate genes.
Lumkul L et al.
The World Allergy Organization Journal, 2023
Base editing screens map mutations affecting interferon-γ signaling in cancer.
Coelho MA et al.
Cancer Cell, 2023
T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma.
Wang J et al.
Frontiers in Immunology, 2022
Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing.
Varzari A et al.
Frontiers in Genetics, 2022
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.
Bin L et al.
Allergy, 2021
Whole-exome sequencing reveals a rare interferon gamma receptor 1 mutation associated with myasthenia gravis.
Qi G et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2018
IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database.
van de Vosse E et al.
Human Mutation, 2017
Missense splice variant (g.20746A>G, p.Ile183Val) of interferon gamma receptor 1 (IFNGR1) coincidental with mycobacterial osteomyelitis - a screen of osteoarticular lesions.
Bińczak-Kuleta A et al.
Bosnian Journal of Basic Medical Sciences, 2016
Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.
Gao L et al.
The Journal of Allergy and Clinical Immunology, 2015
Evolutionary genetics evidence of an essential, nonredundant role of the IFN-γ pathway in protective immunity.
Manry J et al.
Human Mutation, 2011
Functional analysis of naturally occurring amino acid substitutions in human IFN-gammaR1.
van de Wetering D et al.
Molecular Immunology, 2010
A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection.
Zhou J et al.
Immunogenetics, 2009
Correlation between some Th1 and Th2 cytokine receptor gene polymorphisms and systemic lupus erythematosus in Chinese patients.
Xu Y et al.
International Journal of Dermatology, 2007
The interferon-gamma receptor gene polymorphisms (Val14Met and Gln64Arg) are not associated with systemic lupus erythematosus in Chinese patients.
Yao X et al.
Archives of Dermatological Research, 2007
IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women.
Guglielmi L et al.
Allergy, 2006
IFNGR1 single nucleotide polymorphisms in rheumatoid arthritis.
Mattyasovszky S et al.
Arthritis Research & Therapy, 2006
[Polymorphisms within the interferon-Gamma receptor associated with systemic lupus erythematosus].
Yao X et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2005
Defects in the interferon-gamma and interleukin-12 pathways.
Rosenzweig SD et al.
Immunological Reviews, 2005
No association between interferon-gamma receptor-1 gene polymorphism and pulmonary tuberculosis in a Gambian population sample.
Awomoyi AA et al.
Thorax, 2004
Congenital defects in the interferon-gamma/interleukin-12 pathway.
Rosenzweig SD et al.
Current Opinion in Pediatrics, 2004
Missense mutations of the interleukin-12 receptor beta 1(IL12RB1) and interferon-gamma receptor 1 (IFNGR1) genes are not associated with susceptibility to lepromatous leprosy in Korea.
Lee SB et al.
Immunogenetics, 2003
Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma.
Nakao F et al.
The Journal of Allergy and Clinical Immunology, 2001
Receptor polymorphisms and diseases.
Császár A et al.
European Journal of Pharmacology, 2001
The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus.
Nakashima H et al.
Febs Letters, 1999
Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus.
Tanaka Y et al.
Immunogenetics, 1999